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SUMMARY. The comparative antidepressant activity of the extracts of Hypericum perforatum and Ros-
marinus officinalis using animal models of depression were evaluated. The herbal extracts of Hypericum
perforatum (20 mg/kg/p.o.), Rosmarinus officinalis (500 mg/kg/p.o.) were subjected for its antidepressant
activity using four different animal models of depression, viz: Forced Swimming Test (FST), Reserpine
Reversal Test (RRT), Haloperidol-Induced Catalepsy (HIC), and Pentobarbitone Sleeping Time (PST) in
male Wistar rats. The study after single oral administration of Hypericum perforatum and Rosmarinus of-
ficinalis extracts revealed a statistically significant reduction in immobility time in FST, RRT, and protec-
tion against HIC, compared to control respectively. However, there was no significant potentiation of PST.
The results of our study demonstrate the extracts of Hypericum perforatum and Rosmarinus officinalis
proved to have a promising antidepressant potential.
